Innovative Practice in Breast Health

Elsevier

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Innovative Practice in Breast Health is an open-access journal published by Elsevier in France, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,950 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2950-2128
Country
France
Languages
english
Access
Open access
Declared publication charge
2,950 USD
Articles in DOAJ
25
Declared review time
14 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2026-02-19
Indexing
DOAJ
APC
2,950 USD
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

25

Most recent article

7 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

29

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

3

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy10
Added to DOAJ
2026-02-19
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
83%
ORCID iDs in current deposits
80%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Medicine (General): Medical technologyMedicine: Internal medicine

LCC codes

R855-855.5RC31-1245

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • AI in cancer detection
  • AI in cancer detection
  • Breast Implant and Reconstruction
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer
Show all subjects (50)
  • Breast Lesions and Carcinomas
  • Radiomics and Machine Learning in Medical Imaging
  • BRCA gene mutations in cancer
  • Radiomics and Machine Learning in Medical Imaging
  • Global Cancer Incidence and Screening
  • Reconstructive Surgery and Microvascular Techniques
  • Global Cancer Incidence and Screening
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer survivorship and care
  • HER2/EGFR in Cancer Research
  • Digital Radiography and Breast Imaging
  • Cancer Treatment and Pharmacology
  • Infrared Thermography in Medicine
  • Brain Tumor Detection and Classification
  • Infrared Thermography in Medicine
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Digital Radiography and Breast Imaging
  • Cancer survivorship and care
  • Brain Tumor Detection and Classification
  • Ion channel regulation and function
  • Monoclonal and Polyclonal Antibodies Research
  • Pleural and Pulmonary Diseases
  • Cutaneous Melanoma Detection and Management
  • Palliative Care and End-of-Life Issues
  • Cutaneous Melanoma Detection and Management
  • Palliative Care and End-of-Life Issues
  • Ion channel regulation and function
  • CRISPR and Genetic Engineering
  • Ferroptosis and cancer prognosis
  • Monoclonal and Polyclonal Antibodies Research
  • Virus-based gene therapy research
  • Gene expression and cancer classification
  • LGBTQ Health, Identity, and Policy
  • Pleural and Pulmonary Diseases
  • Ferroptosis and cancer prognosis
  • Ion Channels and Receptors
  • Ion Channels and Receptors
  • LGBTQ Health, Identity, and Policy
  • Virus-based gene therapy research
  • Gene expression and cancer classification
  • CRISPR and Genetic Engineering

Keywords (DOAJ)

  • breast diseases
  • artificial intelligence
  • data science
  • surgery
  • imaging
  • oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: